Status:
TERMINATED
Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study
Lead Sponsor:
Penn State University
Conditions:
Seizures
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
It is unclear how enteral nutrition via a feeding tube should be given when a patient is receiving enteral Dilantin. Some caregivers hold the feedings for one hour before and one hour after the Dilant...
Detailed Description
Rationale: It is unclear how enteral nutrition via feeding tube should be given when a patient is receiving enteral Dilantin. Some caregivers hold the feedings for one hour before and one hour after t...
Eligibility Criteria
Inclusion
- On Dilantin for seizure prophylaxis (dose determined by primary caregiver) with therapeutic Dilantin levels
- Receiving enteral nutrition by the interrupted method at goal feeding rate
- Age \>18
- Feeding tube in proper position, no restriction as to type of feeding tube (nasogastric, nasoduodenal, gastrostomy, jejunostomy), but both Dilantin and enteral feeding must be given through the same tube
Exclusion
- History of seizures
- Albumin infusions necessary during study period
- Anticipation that feedings will need to be held for more than 4 hours at a time
- Patients that do not maintain stable Dilantin levels (\< 25% variability) with the interrupted method of feeding
- Inability to obtain consent from patient or spokesperson
Key Trial Info
Start Date :
August 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT00219479
Start Date
August 1 1997
End Date
December 1 2007
Last Update
November 24 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.